Acetylcysteine

Activated charcoal can adsorb acetylcysteine, reducing its bioavailability and efficacy, especially when given orally for paracetamol overdose.

If activated charcoal is administered, it should be given at least 1-2 hours before or after oral acetylcysteine to minimize adsorption. In cases of severe paracetamol overdose, IV acetylcysteine is preferred if activated charcoal has been given.

Source: DDInter

Acetylcysteine can potentiate the vasodilatory and hypotensive effects of nitroglycerin by increasing nitric oxide bioavailability. This can lead to significant hypotension and headache.

Monitor blood pressure closely if co-administering acetylcysteine with nitroglycerin. Consider reducing the dose of nitroglycerin or discontinuing acetylcysteine if severe hypotension occurs. This interaction is sometimes exploited therapeutically in specific cardiac conditions, but requires careful monitoring.

Acetylcysteine can be incompatible with certain antibiotics in vitro, potentially reducing their activity if mixed directly. This is primarily relevant for nebulized or intravenous co-administration, not typically for oral forms.

Do not mix acetylcysteine directly with antibiotics in the same nebulizer or intravenous solution. Administer them separately. For oral administration, this interaction is generally not clinically significant.

Some in vitro and animal studies suggest carbamazepine, an inducer of CYP enzymes, might theoretically increase the metabolism of paracetamol to its toxic metabolite, potentially requiring higher doses of acetylcysteine for effective detoxification. However, clinical significance in humans is not we

While not a strong interaction, clinicians should be aware that patients on enzyme-inducing anticonvulsants might theoretically require a higher or longer course of acetylcysteine in cases of paracetamol overdose, though current guidelines do not routinely recommend dose adjustments based solely on this. Close monitoring of liver function is paramount.

Acetylcysteine can chelate metal ions, including iron. This could theoretically reduce the absorption of oral iron supplements if taken concurrently.

Separate the administration of oral iron supplements and acetylcysteine by at least 2 hours to minimize potential chelation and ensure adequate absorption of iron.

While not a direct interaction, acetylcysteine's role in liver protection and antioxidant effects could theoretically, in very rare cases or specific patient populations (e.g., severe liver injury), indirectly influence coagulation factors synthesized by the liver. However, direct evidence of clinic

Monitor INR more frequently if acetylcysteine is initiated or discontinued in patients on warfarin, especially in those with underlying liver dysfunction. This is a precautionary measure rather than a well-established interaction.